Leonard E. Post
Director, PRAECIS PHARMACEUTICALS INC.
Companies
- CG Oncology, Inc.Board member Jan 24, 2024 to now1
- uniQure N.V.Board member Jun 23, 2020 to now2
- Fulgent GeneticsBoard member Aug 3, 2022 to Aug 3, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- uniQure N.V. QURE35,494 shares4$799.3K at $22.52Jun 11, 2026
Fulgent Genetics FLGT8,000 shares5$170.7K at $21.34Aug 1, 2022- CG Oncology, Inc. CGON0 shares6Sep 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Sold 1,000 shares at $72.98 of CG Oncology, Inc.6
- Sep 15, 2026Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.6
- Aug 14, 2026Sold 1,000 shares at $74.54 of CG Oncology, Inc.7
- Aug 14, 2026Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.7
- Jul 15, 2026Sold 1,000 shares at $71.17 of CG Oncology, Inc.8
- Jul 15, 2026Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.8
- Jun 24, 2026Sold 5,000 shares at $70.00 of CG Oncology, Inc.9
- Jun 24, 2026Exercised options 5,000 shares at $0.60 of CG Oncology, Inc.9
- Jun 22, 2026Sold 5,000 shares at $65.00 of CG Oncology, Inc.10
- Jun 22, 2026Exercised options 5,000 shares at $0.60 of CG Oncology, Inc.10
- Jun 11, 2026Sold 1,993 shares at $27.06 of uniQure N.V.4
- Jun 10, 2026Granted 7,550 shares of uniQure N.V.4
- Jun 4, 2026Sold 1,000 shares at $54.50 of CG Oncology, Inc.11
- Jun 4, 2026Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.11
- Nov 17, 2025Sold 1,000 shares at $41.43 of CG Oncology, Inc.12
- Nov 17, 2025Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.12
- Oct 13, 2025Sold 1,000 shares at $43.25 of CG Oncology, Inc.13
- Oct 13, 2025Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.13
- Sep 30, 2025Sold 5,000 shares at $40.09 of CG Oncology, Inc.14
- Sep 30, 2025Exercised options 5,000 shares at $0.60 of CG Oncology, Inc.14
- Sep 15, 2025Sold 1,000 shares at $35.10 of CG Oncology, Inc.15
- Sep 15, 2025Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.15
- Sep 3, 2025Sold 1,000 shares at $28.00 of CG Oncology, Inc.16
- Sep 3, 2025Exercised options 1,000 shares at $0.60 of CG Oncology, Inc.16
- Jul 17, 2025Sold 2,000 shares at $28.00 of CG Oncology, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCG Oncology, Inc., Board member
- 2SEC EDGARuniQure N.V., Board member
- 3SEC EDGARFulgent Genetics, Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Aug 18, 2026
- 8SEC EDGARForm 4 filed Jul 17, 2026
- 9SEC EDGARForm 4 filed Jun 25, 2026
- 10SEC EDGARForm 4 filed Jun 23, 2026
- 11SEC EDGARForm 4 filed Jun 5, 2026
- 12SEC EDGARForm 4 filed Nov 18, 2025
- 13SEC EDGARForm 4 filed Oct 15, 2025
- 14SEC EDGARForm 4 filed Oct 1, 2025
- 15SEC EDGARForm 4 filed Sep 16, 2025
- 16SEC EDGARForm 4 filed Sep 4, 2025
- 17SEC EDGARForm 4 filed Jul 18, 2025